Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »Here is the ethical issue for targeting volunteers with COVID-19 to accelerate a vaccine
Despite the urgency of beating COVID-19, health officials may delay the development of an effective vaccine. Authorities in the U.S. and elsewhere have yet to authorize an ethical charge investigation procedure called “trials with human challenge.” Challenge tests deliberately involve volunteers with the disease – which explains the official retention …
Read More »Amazon to help Toyota build cloud-based data services
Signature seen at Amazon facility in Bethpage on Long Island, New York, USA, March 17, 2020. REUTERS / Andrew Kelly (Reuters) – Amazon.com Inc’s (AMZN.O) Cloud Computing Unit will be the Japanese Toyota Motor Corp (7203.T) build a platform to help manage and monetize data collected from the automaker’s global …
Read More »Novavax delivers 60 million doses of COVID-19 vaccine candidate to UK
(Reuters) – US drug developer Novavax Inc said on Friday that the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373. FILE PHOTO: A woman holds a small bottle labeled “Vaccine COVID-19” and a medical syringe in this illustration April 10, 2020. REUTERS / Dado Ruvic / …
Read More »Three more U.S. states are launching coronavirus exposure warning apps
OAKLAND, Caliph. (Reuters) – North Dakota, Wyoming and Alabama are the latest U.S. states to launch apps to warn users about potential exposure to the new coronavirus by following their conversations, state officials told Reuters on Thursday. FILE PHOTO: The 1919 mobile app, which North Dakota and South Dakota officials …
Read More »